These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10503813)

  • 1. Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.
    Sebastian M; Makkar R
    Drugs Aging; 1999 Sep; 15(3):207-18. PubMed ID: 10503813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IIb/IIIa receptor blockade in acute myocardial infarction.
    Ferguson JJ; Taqi K
    Am Heart J; 1999 Aug; 138(2 Pt 2):S164-70. PubMed ID: 10426877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb/IIIa receptor antagonists in the management of cardiovascular diseases.
    Chong PH
    Am J Health Syst Pharm; 1998 Nov; 55(22):2363-86. PubMed ID: 9825033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on glycoprotein IIb/IIIa receptor antagonist].
    Rasmussen LH; Husted SE; Clemmensen PM; Gøtzsche CO; Helqvist S; Kristensen SD; Pedersen KE; Rasmussen K; Rasmussen S
    Ugeskr Laeger; 2000 Oct; 162(44):5944-7. PubMed ID: 11094564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose fibrinolytics and glycoprotein IIb/IIIa receptor blockade for the treatment of acute myocardial infarction.
    Ferrario M; Repetto A; Lucreziotti S; Ardissino D
    Am Heart J; 1999 Aug; 138(2 Pt 2):S121-5. PubMed ID: 10426870
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
    Van de Werf F
    Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of platelet glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes.
    Stringer KA
    Ann Pharmacother; 1999 Jun; 33(6):712-22. PubMed ID: 10410186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
    Colombo A; Briguori C
    Am Heart J; 1999 Aug; 138(2 Pt 2):S153-7. PubMed ID: 10426875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.
    Liu F; Craft RM; Morris SA; Carroll RC
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2673-87. PubMed ID: 11060829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet glycoprotein IIb/IIIa receptor antagonists.
    Casserly IP; Moliterno DJ
    Expert Opin Pharmacother; 2000 Mar; 1(3):419-33. PubMed ID: 11249527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Review on Glycoprotein IIb/IIIa Inhibitors as Antiplatelet Agents: Basic and Clinical Perspectives.
    Sharifi-Rad J; Sharopov F; Ezzat SM; Zam W; Ademiluyi AO; Oyeniran OH; Adetunji CO; Roli OI; Živković J; Martorell M; Docea AO; El Omari N; Bouyahya A; Lorenzo JM; Calina D
    High Blood Press Cardiovasc Prev; 2023 Mar; 30(2):93-107. PubMed ID: 36637623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein IIb/IIIa platelet receptor inhibitors: a new dimension in cardiology.
    Tan HC
    Ann Acad Med Singap; 1997 Jul; 26(4):481-8. PubMed ID: 9395815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet drugs. A comparative review.
    Schrör K
    Drugs; 1995 Jul; 50(1):7-28. PubMed ID: 7588091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective use of platelet glycoprotein IIb/IIIa receptor blockers in the emergency department setting.
    Gibler WB; Wilcox RG; Bode C; Castaigne AD; Delooz H; Elich D; Fox KA; Kereiakes DJ; Rupprecht H; Topol EJ
    Eur J Emerg Med; 1998 Dec; 5(4):391-402. PubMed ID: 9919443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-GPIIb/IIIa drugs: current strategies and future directions.
    Coller BS
    Thromb Haemost; 2001 Jul; 86(1):427-43. PubMed ID: 11487034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors.
    Dobesh PP; Latham KA
    Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.